Articles with public access mandates - Steven WoloshinLearn more
Not available anywhere: 4
Physicians’ Perspectives On FDA Regulation Of Drugs And Medical Devices: A National Survey: Study examines physicians’ perspectives, gathered from a national survey, on FDA …
SS Dhruva, AS Kesselheim, S Woloshin, RZ Ji, Z Lu, JJ Darrow, ...
Health Affairs 43 (1), 27-35, 2024
Mandates: Arnold Ventures LLC
Physician Perspectives on the Food and Drug Administration's Decision to Grant Accelerated Approval to Aducanumab for Alzheimer's Disease
SS Dhruva, AS Kesselheim, S Woloshin, RZ Ji, Z Lu, JJ Darrow, ...
Clinical Pharmacology & Therapeutics 114 (3), 614-617, 2023
Mandates: US National Institutes of Health, US Department of Veterans Affairs, Arnold …
Patient perspectives on evidence supporting drug safety and effectiveness:“What does it mean for me?”
LZG Rand, S McGraw, J Wang, S Woloshin, SV Wang, J Darrow, ...
Journal of the American Geriatrics Society, 2024
Mandates: Arnold Ventures LLC
Authors’ reply to Quantrill, Benger, Ripley and colleagues, Roach, Rogers, and Haldar and colleagues
RS Wiener, LM Schwartz, S Woloshin
BMJ 347, 2013
Mandates: US National Institutes of Health
Available somewhere: 43
Time trends in pulmonary embolism in the United States: evidence of overdiagnosis
RS Wiener, LM Schwartz, S Woloshin
Archives of internal medicine 171 (9), 831-837, 2011
Mandates: US National Institutes of Health
Population-based risk for complications after transthoracic needle lung biopsy of a pulmonary nodule: an analysis of discharge records
RS Wiener, LM Schwartz, S Woloshin, HG Welch
Annals of internal medicine 155 (3), 137-144, 2011
Mandates: US National Institutes of Health
Do physicians understand cancer screening statistics? A national survey of primary care physicians in the United States
O Wegwarth, LM Schwartz, S Woloshin, W Gaissmaier, G Gigerenzer
Annals of internal medicine 156 (5), 340-349, 2012
Mandates: US National Institutes of Health
When a test is too good: how CT pulmonary angiograms find pulmonary emboli that do not need to be found
RS Wiener, LM Schwartz, S Woloshin
Bmj 347, 2013
Mandates: US National Institutes of Health
Using a drug facts box to communicate drug benefits and harms two randomized trials: Two randomized trials
LM Schwartz, S Woloshin, HG Welch
Annals of internal medicine 150 (8), 516-527, 2009
Mandates: US National Institutes of Health
Overdiagnosis: what it is and what it isn’t
J Brodersen, LM Schwartz, C Heneghan, JW O’Sullivan, JK Aronson, ...
BMJ evidence-based medicine 23 (1), 1-3, 2018
Mandates: National Institute for Health Research, UK, Wellcome Trust
Influence of medical journal press releases on the quality of associated newspaper coverage: retrospective cohort study
LM Schwartz, S Woloshin, A Andrews, TA Stukel
Bmj 344, 2012
Mandates: US National Institutes of Health
The risk of death by age, sex, and smoking status in the United States: putting health risks in context
S Woloshin, LM Schwartz, HG Welch
Journal of the National Cancer Institute 100 (12), 845-853, 2008
Mandates: US National Institutes of Health
Too little? too much? primary care physicians' views on US health care: a brief report
BE Sirovich, S Woloshin, LM Schwartz
Archives of internal medicine 171 (17), 1582-1585, 2011
Mandates: US National Institutes of Health
When do changes in cancer survival mean progress? The insight from population incidence and mortality
H Cho, AB Mariotto, LM Schwartz, J Luo, S Woloshin
Journal of the National Cancer Institute Monographs 2014 (49), 187-197, 2014
Mandates: US National Institutes of Health
What do you mean, a spot?: A qualitative analysis of patients' reactions to discussions with their physicians about pulmonary nodules
RS Wiener, MK Gould, S Woloshin, LM Schwartz, JA Clark
Chest 143 (3), 672-677, 2013
Mandates: US National Institutes of Health
Press releases by academic medical centers: not so academic?
S Woloshin, LM Schwartz, SL Casella, AT Kennedy, RJ Larson
Annals of Internal Medicine 150 (9), 613-618, 2009
Mandates: US National Institutes of Health
Communicating data about the benefits and harms of treatment: a randomized trial
S Woloshin, LM Schwartz
Annals of internal medicine 155 (2), 87-96, 2011
Mandates: US National Institutes of Health
Resource use and guideline concordance in evaluation of pulmonary nodules for cancer: too much and too little care
RS Wiener, MK Gould, CG Slatore, BG Fincke, LM Schwartz, S Woloshin
JAMA internal medicine 174 (6), 871-880, 2014
Mandates: US National Institutes of Health
Cancer screening campaigns—getting past uninformative persuasion
S Woloshin, LM Schwartz, WC Black, BS Kramer
New England Journal of Medicine 367 (18), 1677-1679, 2012
Mandates: US National Institutes of Health
Providing clinicians and patients with actual prognosis: cancer in the context of competing causes of death
N Howlader, AB Mariotto, S Woloshin, LM Schwartz
Journal of the National Cancer Institute Monographs 2014 (49), 255-264, 2014
Mandates: US National Institutes of Health
Publication and funding information is determined automatically by a computer program